Targeting Metastatic Colorectal Cancer with Immune Oncological Therapies

Targeting Metastatic Colorectal Cancer with Immune Oncological Therapies

Metastatic colorectal cancer carries poor prognosis, and current therapeutic regimes convey limited improvements in survival and high rates of detrimental side effects in patients that may not stand to benefit. Immunotherapy has revolutionised cancer treatment by restoring antitumoural mechanisms. H...

Full description

Bibliographic Details
Main Authors:	Norman J. Galbraith, Colin Wood, Colin W. Steele
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Cancers
Subjects:	colorectal cancer immunotherapy metastases immune checkpoint inhibitors anti-PD1 tumour microenvironment
Online Access:	https://www.mdpi.com/2072-6694/13/14/3566

Similar Items

Tumour-immune dynamics with an immune checkpoint inhibitor
by: Elpiniki Nikolopoulou, et al.
Published: (2018-06-01)

Case Report: Pulmonary Metastases From Epithelioid Sarcoma in Extremity Favourably Responding to Immunotherapy With Camrelizumab
by: Tao-Jun Gong, et al.
Published: (2021-10-01)

Research Progress of Immune Checkpoint Therapy on Colorectal Cancer
by: CAO Qihua, et al.
Published: (2021-03-01)

The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
by: Linda Quatrini, et al.
Published: (2020-11-01)

Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program
by: Massimo Granai, et al.
Published: (2020-05-01)

Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
by: Andrew M. K. Law, et al.
Published: (2020-02-01)

Challenges and Opportunities for Effective Cancer Immunotherapies
by: Clare Y. Slaney, et al.
Published: (2020-10-01)

Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer
by: Rhynelle S. Dmello, et al.
Published: (2021-02-01)

Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival?
by: Emmanouil Damilakis, et al.
Published: (2020-04-01)

Immune landscape and biomarkers for immuno-oncology in colorectal cancers
by: Jeong Mo Bae, et al.
Published: (2020-09-01)

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
by: Mark Yarchoan, et al.
Published: (2020-02-01)

Advances of immune checkpoints in colorectal cancer treatment
by: Qinlian Jiao, et al.
Published: (2020-03-01)

Cancer immunotherapy: Pros, cons and beyond
by: Shuzhen Tan, et al.
Published: (2020-04-01)

Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma
by: Byeong-Joo Noh, et al.
Published: (2020-01-01)

Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
by: Chia-Lang Hsu, et al.
Published: (2021-05-01)

Immune oncology, immune responsiveness and the theory of everything
by: Tolga Turan, et al.
Published: (2018-06-01)

Immune Contexture of MMR-Proficient Primary Colorectal Cancer and Matched Liver and Lung Metastases
by: Maarit Ahtiainen, et al.
Published: (2021-03-01)

Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
by: Bai X, et al.
Published: (2019-11-01)

The Efficacy and Safety of Regorafenib in Combination With Anti-PD-1 Antibody in Refractory Microsatellite Stable Metastatic Colorectal Cancer: A Retrospective Study
by: Jisheng Li, et al.
Published: (2020-11-01)

A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies
by: Tyler J. Nielsen, et al.
Published: (2021-03-01)

Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis
by: Yu X, et al.
Published: (2020-11-01)

Immuno-related endocrinopathy in patients treated with immune checkpoint inhibitors
by: D. I. Yudin, et al.
Published: (2020-07-01)

Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
by: Yuxiao Song, et al.
Published: (2020-08-01)

Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis
by: Jiahang Mo, et al.
Published: (2020-01-01)

Current Treatments of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitors—2020 Update
by: Gerhard Jung, et al.
Published: (2020-10-01)

Perspectives on Immunotherapy of Metastatic Colorectal Cancer
by: Yongjiu Dai, et al.
Published: (2021-06-01)

Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells
by: Stefan Forster, et al.
Published: (2020-11-01)

Combinatorial Immunotherapies for Metastatic Colorectal Cancer
by: Eline Janssen, et al.
Published: (2020-07-01)

The Emerging Role of Checkpoint Inhibition in Microsatellite Stable Colorectal Cancer
by: David J. Hermel, et al.
Published: (2019-01-01)

Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
by: Chongxian Pan, et al.
Published: (2020-04-01)

Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
by: Vida Vafaizadeh, et al.
Published: (2020-03-01)

CCR5 status and metastatic progression in colorectal cancer
by: Meggy Suarez-Carmona, et al.
Published: (2019-09-01)

Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation—A Special Reference to Colorectal Cancer
by: Asimina Koulouridi, et al.
Published: (2021-12-01)

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade
by: T. Anders Olsen, et al.
Published: (2021-06-01)

Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases
by: Takehiro Tozuka, et al.
Published: (2020-09-01)

Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors
by: Deirdre Kelly, et al.
Published: (2021-07-01)

An exceptional response to immunotherapy with chemotherapy in metastatic lung cancer
by: Xenia Elena BACINSCHI, et al.
Published: (2020-06-01)

A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
by: Qian Huang, et al.
Published: (2020-12-01)

The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
by: Andrew A. Davis, et al.
Published: (2019-10-01)

AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer
by: Carlotta Antoniotti, et al.
Published: (2020-07-01)

Cannot write session to /tmp/vufind_sessions/sess_lertkohvi8vd2co59imot507fe